NEW YORK, July 30, 2012 /PRNewswire/ -- Icon plc
(NASDAQ: ICLR: $24) has been picked
by S&P Capital IQ as its Focus Stock of the Week. ICLR's
American depositary shares (ADSs) carry S&P Capital IQ's
highest investment recommendation of 5-STARS, or Strong Buy.
ICLR is a leading global contract research organization (CRO)
providing outsourced clinical research and development services to
the pharmaceutical, biotechnology, and medical devices
industries.
"Large pharmaceutical companies are continually seeking to drive
efficiencies in their drug development processes to reduce costs
associated with the development of new drug candidates and
accelerate time to market," said Jeffrey
Loo, equity analyst at S&P Capital IQ. "This has
resulted in pharmaceutical firms increasingly outsourcing various
research and development functions to CROs, and we believe the main
beneficiaries are the larger global CROs such as ICLR."
To view a video of Mr. Loo discussing ICLR click on the
following link. Weblink to video
About S&P Capital IQ
S&P Capital IQ, a business line of the McGraw-Hill
Companies (NYSE: MHP), is a leading provider of multi-asset class
and real time data, research and analytics to institutional
investors, investment and commercial banks, investment advisors and
wealth managers, corporations and universities around the world. We
provide a broad suite of capabilities designed to help track
performance, generate alpha, identify new trading and investment
ideas, and perform risk analysis and mitigation strategies. Through
leading desktop solutions such as Capital IQ, Global Credit Portal
and MarketScope Advisor desktops; enterprise solutions such as
S&P Valuations, and Compustat; and research offerings,
including Leveraged Commentary & Data, Global Market
Intelligence, and company and fund research, S&P Capital IQ
sharpens financial intelligence into the wisdom today's investors
need. For more information visit www.spcapitaliq.com.
For more information contact:
Marc Eiger, Communications,
Tel.: 212-438-1280
marc_eiger@standardandpoors.com
All information provided by S&P Capital IQ is impersonal and
not tailored to the needs of any person, entity or group of
persons. Past performance is no indication of future results.
S&P Capital IQ and its affiliates provide a wide range of
services to, or relating to, many organizations, including issuers
of securities, investment advisers, broker-dealers, investment
banks, other financial institutions and financial intermediaries,
and accordingly may receive fees or other economic benefits from
those organizations, including organizations whose securities or
services they may recommend, rate, include in model portfolios,
evaluate or otherwise address.
This material is not intended as an offer or solicitation for
the purchase or sale of any security or other financial instrument.
Securities, financial instruments or strategies mentioned herein
may not be suitable for all investors. Any opinions expressed
herein are given in good faith, are subject to change without
notice, and are only current as of the stated date of their issue.
Prices, values, or income from any securities or investments
mentioned in this report may fall against the interests of the
investor and the investor may get back less than the amount
invested. Where an investment is described as being likely to yield
income, please note that the amount of income that the investor
will receive from such an investment may fluctuate. Where an
investment or security is denominated in a different currency to
the investor's currency of reference, changes in rates of exchange
may have an adverse effect on the value, price or income of or from
that investment to the investor. The information contained in this
report does not constitute advice on the tax consequences of making
any particular investment decision. This material does not take
into account your particular investment objectives, financial
situations or needs and is not intended as a recommendation of
particular securities, financial instruments or strategies to you
nor is it considered to be investment advice. Before acting on any
recommendation in this material, you should consider whether it is
suitable for your particular circumstances and, if necessary, seek
professional advice.
This material is based upon information that we consider to be
reliable, but neither S&P Capital IQ nor its affiliates warrant
its completeness, accuracy or adequacy and it should not be relied
upon as such. With respect to reports issued to clients in
Japan and in the case of
inconsistencies between the English and Japanese version of a
report, the English version prevails. With respect to reports
issued to clients in German and in the case of inconsistencies
between the English and German version of a report, the English
version prevails. Neither S&P Capital IQ nor its affiliates
guarantee the accuracy of the translation. Assumptions, opinions
and estimates constitute our judgment as of the date of this
material and are subject to change without notice. Neither S&P
Capital IQ nor its affiliates are responsible for any errors or
omissions or for results obtained from the use of this information.
Past performance is not necessarily indicative of future
results.
SOURCE S&P Capital IQ